Skip to main navigation
Skip to search
Skip to main content
Manipal Academy of Higher Education, Manipal, India Home
Help & FAQ
Link opens in a new tab
Search content at Manipal Academy of Higher Education, Manipal, India
Home
Profiles
Research units
Research output
Equipment
Cognitive enhancers-truth vs. hype
Amruta Tripati
, Manu Mathew
,
Veena Nayak
, Laxminarayana Bairy Kurady
*
*
Corresponding author for this work
Department of Pharmacology, Kasturba Medical College, Manipal
Research output
:
Contribution to journal
›
Article
›
peer-review
2
Link opens in a new tab
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cognitive enhancers-truth vs. hype'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer's Disease
100%
AMPA Receptor
100%
Attention Deficit Disorder
100%
Calcium Ion
100%
Cholinergic Receptor Stimulating Agent
100%
Cholinesterase Inhibitor
100%
Citicoline
100%
Disease
100%
Disease Exacerbation
100%
Memantine
100%
Methylphenidate
100%
Modafinil
100%
N Methyl Dextro Aspartic Acid Receptor
100%
Nerve Growth Factor
100%
Neuroactive Substance
100%
Neurotransmitter
100%
Parkinson's Disease
100%
Piracetam
100%
INIS
assets
33%
blood flow
33%
brain
66%
calcium ions
33%
depolarization
33%
diseases
33%
drugs
100%
enzymes
33%
growth factors
33%
hormones
33%
increasing
33%
learning
33%
levels
33%
membranes
33%
metabolism
33%
nerves
33%
nervous system diseases
66%
neurons
33%
planning
33%
populations
33%
receptors
66%
safety
33%
slowing-down
33%
stimulation
33%
surges
33%
Medicine and Dentistry
Acetylcholinesterase Inhibitor
20%
Alzheimer's Disease
20%
AMPA Receptor
20%
Ampakine
20%
Attention Deficit Disorder
20%
Blood Flow
20%
Brain Function
20%
Calcium Ion
20%
Citicoline
20%
Cognitive Function
20%
Disease Exacerbation
20%
Enhancer Region
100%
Hyperkinetic Disorder
20%
Memantine
20%
Mental Function
20%
Methylphenidate
20%
Modafinil
20%
Nerve Growth Factor
20%
Neurotransmitter
20%
NMDA Receptor
20%
Parasympathomimetic Drug
20%
Parkinson's Disease
20%
Piracetam
20%
Synaptic Transmission
20%
Neuroscience
Acetylcholinesterase Inhibitor
20%
Alzheimer's Disease
20%
AMPA Receptor
20%
Ampakine
20%
Attention Deficit Hyperactivity Disorder
20%
Brain Function
20%
Citicoline
20%
Cognitive Function
20%
Enhancer Region
100%
Hyperkinetic Disorder
20%
Memantine
20%
Metabolic Pathway
20%
Methylphenidate
20%
Modafinil
20%
Nerve Growth Factor
20%
Neuroactive Substance
20%
Neurotransmitter
20%
NMDA Receptor
20%
Nootropic
40%
Parasympathomimetic Drug
20%
Parkinson's Disease
20%
Piracetam
20%
Synaptic Transmission
20%